We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
77 hedge funds and large institutions have $567M invested in Crescent Biopharma in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 22
32% more capital invested
Capital invested by funds: $428M → $567M (+$138M)
25% more call options, than puts
Call options by funds: $826K | Put options by funds: $660K
0.01% more ownership
Funds ownership: 1.05% → 1.05% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 81 → 77 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
77
Holders Change
-4
Holders Change %
-4.94%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
32
Reduced
22
Closed
14
Calls
$826K
Puts
$660K
Net Calls
+$166K
Net Calls Change
+$166K
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.06M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.37M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.74M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.5M |
| 5 |
Citigroup
New York
|
-$1.18M |
